| Mota LM, Carneiro JN, Lima RA, et al.
[Reactive Arthritis in HIV-infected patients immunopathogenic aspects.] [English Abstract, Journal Article]
Acta Reumatol Port 2008 Jul-Sep; 33(3):279-87.
Abstract | Full Citation | | Golkocheva-Markova E, Christova I, Stoilov R, et al.
Cross-reaction between Yersinia outer membrane proteins and anti-Borrelia antibodies in sera of patients with Lyme disease. [Journal Article, Research Support, Non-U.S. Gov't]
Clin Microbiol Infect 2008 Sep; 14(9):873-5.
Abstract | Full Citation | | Garnero P, Tabassi NC, Voorzanger-Rousselot N
Circulating Dickkopf-1 and Radiological Progression in Patients with Early Rheumatoid Arthritis Treated with Etanercept. [JOURNAL ARTICLE]
J Rheumatol 2008 Oct 1.
Abstract | Full Citation | | Ozçakar ZB, Yalçinkaya F, Cakar N, et al.
MEFV Mutations Modify the Clinical Presentation of Henoch-Schönlein Purpura. [JOURNAL ARTICLE]
J Rheumatol 2008 Oct 1.
Abstract | Full Citation | | Souza LS, Machado SH, Brenol CV, et al.
Growth Velocity and Interleukin 6 Concentrations in Juvenile Idiopathic Arthritis. [JOURNAL ARTICLE]
J Rheumatol 2008 Oct 1.
Abstract | Full Citation | Find Related Articles | | Calvisi V, Lupparelli S
C-reactive protein changes in the uncomplicated course of arthroscopic anterior cruciate ligament reconstruction. [Journal Article]
Int J Immunopathol Pharmacol 2008 Jul-Sep; 21(3):603-8.
Abstract | Full Citation | | Kelly A, Ramanan AV
A case of macrophage activation syndrome successfully treated with anakinra. [JOURNAL ARTICLE]
Nat Clin Pract Rheumatol 2008 Sep 30.
Abstract | Full Citation | | Manimegalai N, Arul Rajamurugan PS, Rajendran CP, et al.
Childhood Reactive Arthritis. [JOURNAL ARTICLE]
J Clin Rheumatol 2008 Sep 24.
Full Citation | Find Related Articles | | Karimi O, Peña AS
Indications and challenges of probiotics, prebiotics, and synbiotics in the management of arthralgias and spondyloarthropathies in inflammatory bowel disease. [Journal Article]
J Clin Gastroenterol 2008 Sep.:S136-41.
Abstract | Full Citation | | Genovese MC, McKay JD, Nasonov EL, et al.
Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. [Journal Article]
Arthritis Rheum 2008 Oct; 58(10):2968-80.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
